3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Rectal Diseases
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neoplasms
1
Hemorrhage
1
Endometriosis
1
Dysplastic Nevus Syndrome
1
Diverticulitis
1
Crohn Disease
1
Constipation
1
Colonic Diseases
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Interventions
HhAntag691
21
Biopsy
11
Imiquimod
10
Aminolevulinic Acid
9
sonidegib
8
Photochemotherapy
8
Nivolumab
8
1-phenyl-3,3-dimethyltriazene
7
methyl 5-aminolevulinate
6
cemiplimab
6
Surgical Procedures, Operative
5
Specimen Handling
5
Radiotherapy
5
Itraconazole
5
pembrolizumab
4
daromun
4
Mohs Surgery
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Curettage
4
Tomography, Optical Coherence
3
Standard of Care
3
Niacinamide
3
Microscopy, Confocal
3
IPI-926
3
CTLA-4 Antigen
3
3-ingenyl angelate
3
tazarotene
2
talimogene laherparepvec
2
relatlimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Basal Cell
×
Sutures
×
Clear all
NCT00586040
2009-04-10
PTB
Massachusetts General Hospital
Phase 2
Completed
40 enrolled